We are live on ! Find out more

Spectral AI

MDAI

Market cap $49.9M

1.55 USD

-0.04

2.52%

At close Updated Sep 16, 4:00 PM EDT

Pre-market

After hours

1.61

+0.06

3.87%

1 day

-2.52%

5 days

-1.27%

1 month

-5.49%

3 months

-14.84%

6 months

20.16%

Year to date

6.9%

1 year

-24.76%

5 years

-84.02%

10 years

-84.02%

About: Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.

Employees: 65

Healthcare Medical Devices

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn Conference

DALLAS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today reflected on its successful participation at the Southern Regional Burn Conference (SRBC), held September 10-12, 2026 in Williamsburg, Virginia.

Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn Conference

Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference

DALLAS, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Vincent Capone, Chief Executive Officer, and David McGuire, Chief Financial Officer, are scheduled to present at the H.C.

Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference

Spectral AI, Inc. (MDAI) Q2 2026 Earnings Call Transcript

Spectral AI, Inc. (MDAI) Q2 2026 Earnings Call Transcript

Spectral AI, Inc. (MDAI) Q2 2026 Earnings Call Transcript

Spectral AI Q2 Earnings Call Highlights

Spectral AI NASDAQ: MDAI said its second-quarter results marked a transition toward commercial operations following the U.S. Food and Drug Administration's De Novo clearance of its DeepView System for burn assessment in May. The company reiterated its 2026 revenue guidance of approximately $18.5 million, which does not assume significant revenue from DeepView system sales.

Spectral AI Q2 Earnings Call Highlights

Spectral AI Announces 2026 Second Quarter Financial Results

Company Continues to Advance Towards First Commercial Sales of the DeepView® System for Burn Indication Strong Cash Position of $14.0 Million at June 30, 2026 DALLAS, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the second quarter ended June 30, 2026 (“Q2 2026”). “Spectral AI has entered the second half of 2026 with tremendous momentum and a clear sense of purpose,” said Vincent Capone, Chief Executive Officer of Spectral AI.

Spectral AI Announces 2026 Second Quarter Financial Results

Spectral AI Schedules 2026 Second Quarter Financial Results and Conference Call

DALLAS, July 29, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the second quarter ended June 30, 2026 on Tuesday, August 11, 2026, after the close of the Nasdaq stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time on the same day to discuss its financial results.

Spectral AI Schedules 2026 Second Quarter Financial Results and Conference Call

Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication

Industry Veteran Brings Two Decades of Experience Driving Growth Through New Product Launches, Training and Education Industry Veteran Brings Two Decades of Experience Driving Growth Through New Product Launches, Training and Education

Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication

DeepView® System Highlighted at the 2026 British Burn Association Annual Conference

DALLAS, June 25, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today reflected on its successful participation at the British Burn Association (BBA) Annual Conference, held on June 17th – 19th at the Nottingham Trent University, Nottingham, England. The Company's DeepView® System was on display and was the subject of multiple podium and poster presentations during the conference, highlighting its contributions to advancing burn care through advanced diagnostic analysis across the globe.

DeepView® System Highlighted at the 2026 British Burn Association Annual Conference

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, is joining the American Board of Wound Management (ABWM) Foundation in celebrating the 10th Annual Wound Healing Awareness Month.

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

Spectral AI to Participate in 2026 British Burn Association Annual Conference

Company Will Showcase FDA-Cleared DeepView® System for Burn Indication Company Will Showcase FDA-Cleared DeepView® System for Burn Indication

Spectral AI to Participate in 2026 British Burn Association Annual Conference

See News Rankings

Price charts implemented using Lightweight Charts™